IR Release

Revision of Consolidated Earmings Forecast and Dividend Forecast（Dividend Increase） for the Fiscal Year Ending March 31, 2027

Takara Holdings Inc. (the “Company”) hereby announces revisions to the consolidated earnings forecast and dividend forecast for the fiscal year ending March 31, 2027, which were released on May 13, 2026, based on recent business performance trends and other factors, as set forth below

1. Revision of Consolidated Earnings Forecast

　(1) Revised figures for the consolidated earnings forecast for the fiscal year ending March 31, 2027 (from April 1, 2026, to March
　　   31, 2027)

(2)Reason for revision

Based on the forecast by business segment, net sales at the Group’s major segments are expected to exceed the previous forecast. At Takara Shuzo Co., Ltd., sales of shochu and other products are expected to increase, while at the Takara Shuzo International Group, both the overseas alcoholic beverages business and Japanese food wholesale business in overseas markets are expected to continue performing strongly. On the other hand, net sales at the Takara Bio Group are expected to fall below the previous forecast due to the anticipated continuation of sluggish conditions in the global life science research market and the failure to secure new contracts in the contract services business in Japan. Nevertheless, consolidated net sales for the Group as a whole are expected to exceed the previous forecast.

Operating profit at the Takara Shuzo International Group is expected to exceed the previous forecast, reflecting higher gross profit resulting from increased net sales as well as the recording of mutual tariff refunds and other factors. In contrast, at Takara Shuzo Co., Ltd., although efforts are being made to improve the efficiency of selling, general and administrative expenses, operating profit is expected to fall below the previous forecast due to a decline in gross profit caused by a higher cost of sales ratio, reflecting increased costs for packaging materials and the impact of foreign exchange fluctuations. At the Takara Bio Group, although net sales are expected to fall below the previous forecast, operating profit is expected to be in line with the previous forecast, reflecting the recording of mutual tariff refunds and lower expenses resulting from a review of consideration based on the development and sales progress of Spatial products. As a result, operating profit for the Group as a whole is expected to exceed the previous forecast.

Profit attributable to owners of the parent is expected to exceed the previous forecast. Although extraordinary losses are expected to increase due to business structure reforms at Takara Bio Inc., including impairment losses on facilities related to contract manufacturing and additional retirement benefit expenses, the positive impact of increased extraordinary gains, including gains on the sale of real estate, is expected to more than offset such losses.

For details of the earnings forecasts by business segment, please refer to the “Supplementary Materials for the Financial Results for the Second Quarter (Interim Period) of the Fiscal Year Ending March 31, 2027” (Pages 10/15 through 15/15) released today.

2. Revision of Dividend Forecast

(1) Details of the Revision

（2）Reason for revision

The Company has adopted a progressive dividend policy under the Takara Group Medium-Term Management Plan 2030, and has set a total return ratio of 50% on a cumulative five-year basis as its shareholder return policy. In light of this policy and the upward revision of the earnings forecast announced today, the Company has revised its dividend forecast for the fiscal year ending March 31, 2027, from 31.00yen per share announced on May 13, 2026, to 34.00yen per share.

Note: This document has been translated from the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese original, the original shall prevail. The Company assumes no responsibility for this translation or for direct, indirect or any other forms of damages arising from the translation.